Yu Ping Feng San Exert Anti-Angiogenesis Effects through the Inhibition of TSLP-STAT3 Signaling Pathways in Hepatocellular Carcinoma

BACKGROUND: Clinically, Yu ping feng san (YPFS) has been extensively used as a medication for treating immune deficiency, and YPFS is combined with chemotherapy drugs to treat cancer, including hepatocellular carcinoma (HCC), lung cancer, and pancreatic cancer. Previous research has shown that YPFS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evid Based Complement Alternat Med
Main Authors: Yuan, Qin, Yao, Fei, Zhou, Liang, Liang, Guoqiang, Song, Xiudao, Jiang, Guorong, Zhou, Man, Zhang, Lurong
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925680/
https://ncbi.nlm.nih.gov/pubmed/31885639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1947156
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados